| Financial Year |
March 31 2023 |
| Monetary Funds |
139,908,773.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
47,660,295.26 |
| Advances to Suppliers |
5,549,956.27 |
| Other Receivables |
1,164,566.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,545,690.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,016,393.71 |
| Total Current Assets |
385,981,142.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
114,748,994.25 |
| Investment Properties |
75,932,278.99 |
| Fixed Assetes |
243,412,721.98 |
| Under-construction Projects |
3,011,571.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,984,486.43 |
| R&D expenses |
-- |
| Goodwill |
3,601,622.31 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
23,614,495.13 |
| Other Non-Current Assets |
42,753,929.37 |
| Sub-Total of Non-Current Assets |
774,672,100.29 |
| Total Assets |
1,160,653,242.52 |
| Short-Term Loans |
92,147,810.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,380,000.00 |
| Accounts Payable |
167,294,989.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,004,661.68 |
| Taxes Payable |
11,725,966.44 |
| Interest Payable |
5,237,195.18 |
| Dividend Payable |
9,913.37 |
| Other payables |
57,493,064.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,782,469.52 |
| Other Current Liabilities |
245,164.30 |
| Sub-Total of Current Liabilities |
382,033,882.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
39,774,628.31 |
| Sub-Total of Non-Current Liabilities |
54,171,724.27 |
| Total Liabilities |
436,205,607.02 |
| Paid-In Capital(Or Share Stock) |
283,331,157.00 |
| Capital Surplus |
1,086,997,727.79 |
| Surplus Reserve |
140,439,908.33 |
| LESS:Treasury Stock |
64,647,530.00 |
| Undistributed Profits |
-600,155,686.39 |
| Minority Stockholder's Interest |
-56,219,967.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
780,667,603.08 |
| Owner's Equity（Stockholder's Equity） |
724,447,635.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,160,653,242.52 |
